regeneron glp-1 gip treatment muscle loss side effects GDF8 and activin A blockade protects against GLP-1–induced while enhancing fat loss in obese male mice and non-human primates Pharmacological treatment for patients with

Schedule a consultation to explore how MATTR can support your metabolic health, body composition, and long-term wellness.

Although substances that increase energy expenditure have existed, their clinical use has been limited due to safety concerns

Alcohol consumed the evening before a morning dose does not meaningfully affect the next morning absorption

Synthetic peptide drugs are not introducing something completely new, just a new form that is mimicking or amplifying signals your body already uses

Gut dysbiosis and long COVID19: Feeling gutted

Three HCC tiers for diabetes (CMS-HCC V28, current as of 20252026): HCC 36: Diabetes with acute complications (highest risk weight) HCC 37: Diabetes with chronic complications: neuropathy, nephropathy, retinopathy, circulatory problems HCC 38: Diabetes without complications (E11.9), lowest risk weight Note: Older resources may reference V24 numbers (HCC 17, 18, 19)